Blocking the PD-1/PD-L1 axis enhanced cisplatin chemotherapy in osteosarcoma in vitro and in vivo
ConclusionThe present data suggested that the blocking of PD-1/PD-L1 axis had a positive prognostic value, which can enhance the chemotherapeutic effect of cisplatin in OS. These findings provide a rationale for utilizing PD1/PD-L1 blocking antibodies as a single agent to cure refractory OS in patients receiving cisplatin treatment.
Source: Environmental Health and Preventive Medicine - Category: Environmental Health Source Type: research
More News: Bone Cancers | Cancer | Cancer & Oncology | Chemotherapy | Environmental Health | Osteosarcoma | Study